Holds one valid CEP for ciclopirox olamine, filing since 2022. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one valid CEP for ciclopirox olamine, filing since 2022. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one valid CEP for ciclopirox olamine, filing since 2023. Its 2023 FDA inspection closed as NAI.
Holds one valid CEP for ciclopirox olamine, filing since 2021. Its 2021 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one valid CEP for ciclopirox olamine, filing since 2025. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 3 markets.
Registered with SFDA (Saudi Arabia) for ciclopirox olamine. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Chat with Fred, your AI analystThe order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for ciclopirox olamine and what filings they hold.
Chat with Fred, your AI analyst